Patents by Inventor Gabriel Hum

Gabriel Hum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11485891
    Abstract: The invention relates to chemical-based methods and products for mitigating the impact of an oil spill, that act via mechanisms which include reducing adhesiveness, herding, thickening and gelling. N-fatty acid amino acid (FA-AA) conjugates display oil-herding behavior when formulated as a salt, or the free acid in water-miscible organic solvents. Various salts of FA-AA conjugates are water soluble and can herd oils and increase the thickness of the oil layer. Replacement of the acid group of fatty acid ?-amino acid conjugates with other groups that act as hydrogen bond donors and acceptors results in potent phase selective organo gellants. The oil thickeners or gellants include can be prepared from biobased feedstocks, have low toxicity, high capacity for oil and reduction of the need to use an organic solvent to apply the thickener or gellant to an oil and water mixture in order to gel the oil phase.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: November 1, 2022
    Assignee: B.C. RESEARCH INC.
    Inventors: Gabriel Hum, Daniel Zachary Kurek, Anwu Li
  • Publication number: 20210230466
    Abstract: Chemical-based methods and products for mitigating the impact of an oil spill are disclosed. The products act by herding, thickening, gelling, and reducing adhesiveness. N-fatty acid amino acid (FA-AA) conjugates display oil-herding behavior when formulated as a free acid in water-miscible organic solvents. A water-miscible organic solvent is not required if the FA-AA conjugate is formulated as a salt. Various salts of FA-AA conjugates are water soluble and can herd oils and increase the thickness of the oil layer. Replacement of the acid group of fatty acid ?-amino acid conjugates with other groups that act as hydrogen bond donors and acceptors results in potent phase selective organo-gellants. The oil spill herders can be prepared from bio-based feedstocks and are biodegradable.
    Type: Application
    Filed: June 5, 2019
    Publication date: July 29, 2021
    Inventors: Gabriel Hum, Daniel Zachary Kurek, Anwu Li
  • Publication number: 20100168103
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type calcium channel activity are disclosed. Specifically, a series of diaryl piperidine compounds are disclosed of the general formula (I) where X is a linker and Y may be C, O, S or N.
    Type: Application
    Filed: September 14, 2007
    Publication date: July 1, 2010
    Applicant: NEUROMED PHARMACEUTICALS LTD.
    Inventors: Hassan Pajouhesh, Yanbing Ding, Hossein Pajouhesh, Richard Holland, Gabriel Hum
  • Publication number: 20090270338
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted N-cyclylalkyl-diphenylpropanamide derivatives as shown in formula (1).
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Inventors: Robert Galemmo, JR., Richard Holland, Gabriel Hum
  • Publication number: 20090270413
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds containing di-t-butyl phenyl piperazine derivatives of the general formula (1).
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Inventors: Robert Galemmo, JR., Gabriel Hum
  • Publication number: 20090270394
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted cyclylamine derivatives as shown in formulas (1).
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Inventors: Robert Galemmo, JR., Richard Holland, Gabriel Hum, Hossein Pajouhesh, Navjot Chahal, Mehran Seid-Bagherzadeh, Amy Girard
  • Publication number: 20090221603
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type or T-type calcium channel activity are disclosed. Specifically, a series of heterocyclic amides are disclosed of the general formula (1) where Z is N or ?CHNR2 and X is NR2, O, S, S?O or SO2. Among other definitions for R, R1, W and Y, the compounds of formula (1) are further characterized by at least one of W or Y being CR3Ar2 where Ar is an aromatic or heteroaromatic ring (for example, where W or Y is a benzhydryl moiety).
    Type: Application
    Filed: December 19, 2006
    Publication date: September 3, 2009
    Inventors: Hassan Pajouhesh, Ramesh Kaul, Yanbing Ding, Gabriel Hum, Hossein Pajouhesh
  • Publication number: 20090012010
    Abstract: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds containing both an amino acid functionality and multiple aromatic rings are disclosed of the general formula (1) where X is benzhydryl, or an aromatic or heteroaromatic ring.
    Type: Application
    Filed: May 14, 2008
    Publication date: January 8, 2009
    Applicant: Neuromed Phramaceuticals Ltd.
    Inventors: Robert Galemmo, JR., Richard Holland, Yanbing Ding, Lingyun Zhang, Gabriel Hum, Navjot Chahal, Joseph Duffy, Christian Stevenson, Andrew Ullman